Interpace Diagnostics Group, Inc.·4

Sep 27, 5:09 PM ET

Richard Gregory 4

4 · Interpace Diagnostics Group, Inc. · Filed Sep 27, 2017

Insider Transaction Report

Form 4
Period: 2017-09-26
Richard Gregory
Chief Commercial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2017-09-26+200,000200,000 total
    Exercise: $1.45Exp: 2018-09-26Common Stock (200,000 underlying)
Footnotes (1)
  • [F1]The stock option award vests and becomes exercisable over a period of one year in twelve equal installments, commencing on the 15th day of each calendar month, subject to the reporting person's continued service with the issuer.

Documents

1 file
  • 4
    form4.xmlPrimary